Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-08-10Clinical Trial Update: Movement Intervention for Memory Enhancement [NA]
A completed clinical trial evaluating a movement intervention for memory enhancement in Alzheimer's disease and dementia, with results poste…
-
CLINICAL_TRIALS trial_result · 2021-08-09Clinical Trial Update: A Single Ascending Dose Study to Investigate the Safety, Tolerability, Immunogenicity and Pharmacokinetics of Intravenously Administered RO7126209 in Healthy Participants [Phase 1]
Phase 1 study assessing safety, tolerability, immunogenicity, and pharmacokinetics of RO7126209 given IV in healthy participants; completed …
-
CLINICAL_TRIALS trial_result · 2021-08-05Clinical Trial Update: A Study of CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease [Phase 2, Phase 3]
A study evaluating CNP520 vs placebo in individuals at risk for onset of Alzheimer's disease was terminated, with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-08-02Clinical Trial Update: AC-1204 26-Week Long Term Efficacy Response Trial With Optional Open-label Ext [Phase 2, Phase 3]
Phase 2/3 clinical trial update for AC-1204 in Alzheimer's disease; study completed with long-term efficacy results and optional open-label …
-
CLINICAL_TRIALS trial_result · 2021-07-29Clinical Trial Update: Sunphenon EGCg (Epigallocatechin-Gallate) in the Early Stage of Alzheimer´s Disease [Phase 2, Phase 3]
Phase 2/3 trial of Sunphenon EGCg (Epigallocatechin-Gallate) in early-stage Alzheimer's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-07-27Clinical Trial Update: Study of APH-1105 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 study update for APH-1105 in patients with mild to moderate Alzheimer's disease (Alzheimer's disease).
-
CLINICAL_TRIALS trial_result · 2021-07-21Clinical Trial Update: Efficacy and Safety of 26-Week Treatment of AR1001 in Patients With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial assessing 26-week AR1001 treatment for efficacy and safety in mild to moderate Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2021-07-19Clinical Trial Update: A Study to Evaluate Efficacy and Safety of BAC in Patient With Alzheimer's Disease or Vascular Dementia [Phase 2]
Phase 2 study updating efficacy and safety of BAC in Alzheimer's disease or vascular dementia; study completed with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of AstroStem in Treatment of Alzheimer's Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the safety and efficacy of AstroStem for Alzheimer's disease has results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Trial of Oxaloacetate in Alzheimer's Disease (TOAD) [Phase 1]
Phase 1 trial update for Oxaloacetate in Alzheimer's disease (TOAD) has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-07-08Clinical Trial Update: A Study of CAD106 and CNP520 Versus Placebo in Participants at Risk for the Onset of Clinical Symptoms of Alzheimer's Disease [Phase 2, Phase 3]
A Phase 2/3 study evaluating CAD106 and CNP520 versus placebo in individuals at risk for developing Alzheimer's disease was terminated; resu…
-
CLINICAL_TRIALS trial_result · 2021-06-29Clinical Trial Update: ITI-007 for the Treatment of Agitation in Patients With Dementia, Including Alzheimer's Disease [Phase 3]
Phase 3 trial of ITI-007 for agitation in dementia, including Alzheimer's disease was terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: the Safety and the Efficacy Evaluation of Allogenic Adipose MSC-Exos in Patients With Alzheimer's Disease [Phase 1, Phase 2]
Phase 1/2 clinical trial evaluating safety and efficacy of allogeneic adipose-derived mesenchymal stem cell exosomes in Alzheimer disease.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: 2-Year Extension Study of Azeliragon in Subjects With Alzheimer's Disease (STEADFAST Extension) [Phase 3]
A 2-year extension study (STEADFAST Extension) of Azeliragon in Alzheimer's disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-06-01Clinical Trial Update: PTI-125 for Mild-to-moderate Alzheimer's Disease Patients [Phase 2]
Phase 2 clinical trial update for PTI-125 in mild-to-moderate Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Effect of Modulating Gamma Oscillations Using tACS [NA]
A completed clinical trial investigating whether modulating gamma oscillations with transcranial alternating current stimulation (tACS) impa…
-
CLINICAL_TRIALS trial_result · 2021-05-20Clinical Trial Update: Videofluoroscopic Swallowing Study (VFSS) [NA]
A Videofluoroscopic Swallowing Study (VFSS) trial sponsored by Nestlé has been terminated; results were posted in 2021 and the study covered…
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: A Safety Study of PTI-125 in Healthy Volunteers [Phase 1]
A Phase 1 safety study of PTI-125 in healthy volunteers has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-07Clinical Trial Update: Evaluation of the Efficacy and Safety of Azeliragon (TTP488) in Patients With Mild Alzheimer's Disease [Phase 3]
Phase 3 trial evaluating Azeliragon (TTP488) for mild Alzheimer's disease was terminated; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: A Phase II Study to Assess the Safety, Tolerability and Efficacy of Xanamem™ in Subjects With Mild Dementia Due to AD (XanADu) [Phase 2]
Phase II study (XanADu) evaluating the safety, tolerability and efficacy of Xanamem in subjects with mild dementia due to Alzheimer's diseas…
-
CLINICAL_TRIALS trial_result · 2021-04-29Clinical Trial Update: Non-invasive Stimulation of Brain Networks and Cognition in Alzheimer's Disease and Frontotemporal Dementia [NA]
Clinical trial investigating non-invasive stimulation of brain networks to influence cognition in Alzheimer's disease and frontotemporal dem…
-
CLINICAL_TRIALS trial_result · 2021-04-28Clinical Trial Update: Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease [Phase 2]
Phase 2 clinical trial update on ORM-12741 for Alzheimer's disease reporting safety and efficacy results.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of LY3202626 on Disease Progression in Participants With Mild Alzheimer's Disease Dementia [Phase 2]
Phase 2 trial update for LY3202626 in mild Alzheimer's disease dementia was terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-19Clinical Trial Update: A Study of LY3202626 in Healthy Participants and Participants With Alzheimer's Disease [Phase 1]
A Phase 1 study of LY3202626 in healthy participants and participants with Alzheimer's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-04-14Clinical Trial Update: Assessment the Efficacy of Acetyl-L-carnitine in Patient With Alzheimer's Disease [Phase 4]
Phase 4 trial assessing the efficacy of Acetyl-L-carnitine in patients with Alzheimer's disease has been completed.